NCT02349477

Gabapentin for Alcohol Relapse Prevention

Gabapentin for Relapse Prevention: Alcohol Withdrawal Effects

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 96 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This treatment study is a 16-weeks outpatient clinical trial where subjects with alcohol dependence will get medication, which might help them to reduce or stop their drinking, or a placebo ( placebo is a capsule that looks the same as the investigational drug, but has no real medication. It is a "sugar pill").

Detailed description

This treatment study is a 16-weeks outpatient clinical trial where subjects will get medication, which might help them to reduce or stop their drinking or a placebo ( placebo is a capsule that looks the same as the investigational drug, but has no real medication. It is a "sugar pill"). This study will recruit and randomize subjects who have expressed an interest in receiving treatment for alcohol dependence. Upon enrollment into this study there will be 11 outpatient visits. Each visit will last about 1-1.5 hours.

Conditions

• Alcohol Use Disorder
• Alcohol Withdrawal

Interventions

Type	Name	Description
DRUG	Gabapentin	gaba potentiating medication
DRUG	Placebo	a pill that looks exactly like the active medication but does not contain medication

Timeline

• Start date: 2014-11-01
• Primary completion: 2018-08-27
• Completion: 2018-08-27
• First posted: 2015-01-29
• Last updated: 2019-11-04
• Results posted: 2019-11-04

Locations

1 site across 1 country: United States